Download Sample
Add to CartArteriotomy Closure Devices Market
By Product;
Active Closure Devices and Passive Closure DevicesBy Closure Mechanism;
Clip Based, Plug Based and Sealant BasedBy Application;
Femoral Arterial Access Procedures and Radial Arterial Access ProceduresBy End User;
Hospitals, Ambulatory Care Centers and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Arteriotomy Closure Devices Market Overview
Arteriotomy Closure Devices Market (USD Million)
Arteriotomy Closure Devices Market was valued at USD 1,350.63 million in the year 2024. The size of this market is expected to increase to USD 1,990.95 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.7%.
Arteriotomy Closure Devices Market
*Market size in USD million
CAGR 5.7 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.7 % |
| Market Size (2024) | USD 1,350.63 Million |
| Market Size (2031) | USD 1,990.95 Million |
| Market Concentration | Medium |
| Report Pages | 367 |
Major Players
- Abbott Laboratories
- Terumo Corporation
- Cardinal Health
- Cardiva Medical
- Merit Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Arteriotomy Closure Devices Market
Fragmented - Highly competitive market without dominant players
The Arteriotomy Closure Devices Market is witnessing steady growth, largely driven by the rising prevalence of cardiovascular diseases and the increasing number of catheter-based interventions. As a minimally invasive solution, arteriotomy closure devices significantly reduce time to hemostasis and patient recovery, making them a preferred choice in modern interventional cardiology. Notably, coronary and peripheral interventions account for nearly 65% of the total demand, highlighting their critical role in improving procedural outcomes.
Innovations in Device Design and Materials
Technological advancements in biodegradable materials and suture-based mechanisms are driving product innovation. Next-generation closure devices are being designed to minimize vascular trauma and improve deployment accuracy. Nearly 30% of new product launches emphasize bio-absorbable components, which reduce long-term risks and improve patient safety, boosting adoption rates globally.
Supportive Healthcare Policies and Investments
Governmental initiatives and evolving healthcare policies are further encouraging the use of arteriotomy closure devices. Investments in cardiovascular health programs and reimbursement support for advanced interventions are improving accessibility. Presently, over 45% of cardiac care programs incorporate closure devices as part of their treatment protocols, strengthening market growth.
Growth Trajectory and Market Potential
With rising cardiovascular procedure volumes and continuous innovation, the arteriotomy closure devices market is poised for robust expansion. Strategic collaborations, clinical research, and technological advancements are creating strong opportunities for manufacturers and healthcare providers in the years ahead.
Arteriotomy Closure Devices Market Recent Developments
- In September 2022, Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that it had earned CE mark certification for its VASCADE vascular closure and VASCADE MVP venous vascular closure systems.
- In May 2023, Teleflex Incorporated announced that it had received Health Canada approval for the MANTA Vascular Closure Device, the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.
Arteriotomy Closure Devices Segment Analysis
In this report, the Arteriotomy Closure Devices Market has been segmented by Product, Application, End User and Geography.
Arteriotomy Closure Devices Market, Segmentation by Product
The Arteriotomy Closure Devices Market has been segmented by Product into Active Closure Devices and Passive Closure Devices.
Active Closure Devices
With a dominant share of around 65%, Active Closure Devices lead the Arteriotomy Closure Devices Market thanks to their effectiveness in achieving quick and reliable vascular closure. They are extensively adopted in cardiology and radiology procedures for minimizing complications, shortening recovery times and enhancing patient comfort.
Passive Closure Devices
Holding close to 35% of the market, Passive Closure Devices remain a viable solution where cost-efficiency and procedural simplicity are key priorities. Although less prevalent than active systems, they are valued in cases requiring lower intervention complexity and in resource-limited healthcare environments.
Arteriotomy Closure Devices Market, Segmentation by Application
The Arteriotomy Closure Devices Market has been segmented by Application into Femoral Arterial Access Procedures and Radial Arterial Access Procedures.
Femoral Arterial Access Procedures
Holding approximately 70% of the global market share, Femoral Arterial Access Procedures remain the leading application segment in the Arteriotomy Closure Devices Market. Their dominance is attributed to high clinical adoption in interventional cardiology and endovascular interventions, thanks to proven procedural efficiency, widespread clinician expertise and compatibility with complex arterial procedures.
Radial Arterial Access Procedures
Comprising nearly 30% of the market, Radial Arterial Access Procedures are experiencing notable growth driven by their ability to minimize post-procedural bleeding risks and enable quicker patient discharge. This approach is gaining traction in outpatient cardiac procedures and minimally invasive cardiovascular therapies, supported by increasing clinician preference for patient-centric recovery benefits.
Arteriotomy Closure Devices Market, Segmentation by End User
The Arteriotomy Closure Devices Market has been segmented by End User into Hospitals, Ambulatory Care Centers and Others.
Hospitals
Representing approximately 65% of the total market share, Hospitals are the largest end-user segment in the Arteriotomy Closure Devices Market. Their dominance is supported by a high concentration of complex cardiovascular and endovascular interventions, advanced medical infrastructure and specialized interventional teams capable of managing diverse patient needs.
Ambulatory Care Centers
Accounting for nearly 25% of the market, Ambulatory Care Centers are witnessing robust growth as the healthcare industry increasingly adopts outpatient-based minimally invasive procedures. These facilities offer the advantages of cost efficiency, rapid patient turnover and reduced hospital stays, making them a preferred choice for certain vascular interventions.
Others
Holding the remaining 10% share, the Others category includes clinics, specialty care units and diagnostic centers. These facilities focus on lower-complexity vascular procedures and post-operative follow-up care, playing a supporting role in the wider adoption of arteriotomy closure solutions.
Arteriotomy Closure Devices Market, Segmentation by Geography
In this report, the Arteriotomy Closure Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Arteriotomy Closure Devices Market Share (%), by Geographical Region.
North America
Commanding about 40% of the Arteriotomy Closure Devices Market, North America benefits from advanced healthcare facilities, a high rate of minimally invasive cardiovascular procedures and strong presence of leading device manufacturers. The region’s mature market environment supports continuous adoption of innovative closure technologies.
Europe
With a share of nearly 25%, Europe is driven by well-established healthcare systems, rising cardiovascular cases and growing demand for efficient vascular closure solutions. An aging population and government-backed healthcare initiatives further enhance market growth.
Asia Pacific
Representing close to 22% of the global market, the Asia Pacific region is experiencing rapid expansion due to the rising volume of cardiovascular surgeries, improving hospital infrastructure and heightened awareness of advanced closure devices across emerging economies.
Middle East & Africa
Holding around 7% of the market, the Middle East & Africa segment is expanding steadily due to healthcare modernization and increasing adoption of minimally invasive medical technologies. Growth is most notable in wealthier Gulf nations.
Latin America
Capturing nearly 6% of the global share, Latin America sees growth fueled by increasing healthcare investment and rising cardiovascular disease prevalence. Brazil and Mexico lead adoption of arteriotomy closure devices in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Arteriotomy Closure Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population Growth
- Increasing Cardiovascular Procedures
- Technological Advancements
-
Rising Demand for Minimally Invasive Surgeries: The rising demand for minimally invasive surgeries (MIS) has significantly influenced the global arteriotomy closure devices market. MIS techniques involve smaller incisions compared to traditional open surgeries, leading to benefits such as reduced recovery times, shorter hospital stay and lower risk of infection. As a result, there is a growing preference among patients and healthcare providers for procedures that utilize arteriotomy closure devices, as these devices facilitate efficient hemostasis and closure of arterial puncture sites following MIS procedures.
Advancements in medical technology have contributed to the expansion of MIS capabilities, enabling more complex procedures to be performed minimally invasively. Arteriotomy closure devices play a crucial role in supporting these advancements by providing reliable and effective closure solutions that are essential for ensuring procedural success and minimizing post-operative complications. This trend is further driven by the continuous innovation in closure device designs, which aim to enhance sealing efficacy, reduce procedure time and improve overall patient outcomes.
The increasing adoption of arteriotomy closure devices in conjunction with MIS reflects a broader healthcare trend towards enhancing patient comfort and optimizing surgical outcomes. As healthcare systems worldwide continue to prioritize cost-effective and efficient treatment options, the demand for arteriotomy closure devices is expected to rise, presenting opportunities for market growth and innovation in the years ahead.
Restraints
- High Cost of Devices
- Lack of Reimbursement
- Complications Associated
-
Regulatory Challenges: Regulatory challenges represent a significant hurdle for manufacturers in the global arteriotomy closure devices market. These devices are subject to stringent regulations and approval processes imposed by regulatory bodies such as the FDA in the United States and the CE Marking in Europe. Compliance with these regulations is essential for ensuring the safety, efficacy and quality of arteriotomy closure devices before they can be marketed and used in clinical settings.
Navigating regulatory pathways can be complex and time-consuming, requiring manufacturers to invest substantial resources in clinical trials, quality management system, and documentation to demonstrate product safety and performance. Delays or uncertainties in regulatory approvals can impact product launches and market entry timelines, potentially affecting competitive positioning and revenue generation.
Regulatory requirements may vary across different regions, necessitating manufacturers to adapt their strategies and product designs to meet diverse compliance standards. These challenges underscore the importance of regulatory expertise and proactive engagement with regulatory authorities throughout the product development lifecycle. Despite these challenges, regulatory compliance remains crucial for maintaining patient safety and fostering trust among healthcare providers, ensuring that arteriotomy closure devices meet the highest standards of quality and efficacy in clinical practice.
Opportunities
- Emerging Markets Expansion
- Development of Bioresorbable Materials
- Strategic Partnerships
-
Enhanced Patient Outcomes: Enhanced patient outcomes are a central focus in the development and adoption of arteriotomy closure devices within the healthcare landscape. These devices are designed not only to achieve effective closure of arterial puncture sites but also to contribute to improved patient recovery and overall treatment success. By promoting faster hemostasis and reducing the risk of complications such as bleeding and infection, arteriotomy closure devices help enhance post-procedural comfort and facilitate earlier discharge from hospitals.
The advancement of closure device technologies plays a critical role in optimizing patient outcomes by minimizing procedural risks and supporting quicker recovery times. Innovations such as bioresorbable materials, which dissolve over time within the body, are gaining traction as they eliminate the need for device removal procedures and further enhance patient convenience. Moreover, these devices are increasingly being integrated with hemostatic agents and advanced sealing mechanisms to enhance efficacy and reliability in achieving immediate hemostasis, thereby contributing to improved clinical outcomes and patient satisfaction.
As healthcare systems worldwide prioritize value-based care and patient-centered outcomes, the demand for arteriotomy closure devices that not only meet regulatory standards but also enhance recovery experiences is expected to grow. Manufacturers and healthcare providers continue to collaborate on refining device designs and procedural techniques to further optimize outcomes, ensuring that arteriotomy closure devices play a pivotal role in advancing patient care across cardiovascular procedures.
Competitive Landscape Analysis
Key players in Global Arteriotomy Closure Devices Market include
- Abbott Laboratories
- Terumo Corporation
- Cardinal Health
- Cardiva Medical
- Merit Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Closure Mechanism
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Arteriotomy Closure Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population Growth
- Increasing Cardiovascular Procedures
- Technological Advancements
- Rising Demand for Minimally Invasive Surgeries
- Restraints
- High Cost of Devices
- Lack of Reimbursement
- Complications Associated
- Regulatory Challenges
- Opportunities
- Emerging Markets Expansion
- Development of Bioresorbable Materials
- Strategic Partnerships
- Enhanced Patient Outcomes
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Arteriotomy Closure Devices Market, By Product, 2021 - 2031 (USD Million)
- Active Closure Devices
- Passive Closure Devices
-
Arteriotomy Closure Devices Market, By Closure Mechanism, 2021 - 2031 (USD Millio)
-
Clip Based
-
Plug Based
-
Sealant Based
-
- Arteriotomy Closure Devices Market, By Application, 2021 - 2031 (USD Millio)
- Femoral Arterial Access Procedures
- Radial Arterial Access Procedures
- Arteriotomy Closure Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Care Centers
- Others
- Arteriotomy Closure Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Arteriotomy Closure Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Terumo Corporation
- Cardinal Health
- Cardiva Medical
- Merit Medica
- Company Profiles
- Analyst Views
- Future Outlook of the Market